Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Sep 27, 2022 12:43pm
81 Views
Post# 34989727

RE:RE:RE:57,000 views, THTX YouTube video link below

RE:RE:RE:57,000 views, THTX YouTube video link belowIt can be a mix of many factors. The confusing thing is that the little rise happened the day of their PR where they announce a business update. All indirect signs point to a positive update and again, in July they had three more PRs before the CC, all with good news.

SPCEO1 wrote: Another possible explantion is TH met with some institution very early yesterday morning for breakfast and they immediately started buying the stock from the breakfast table they were seated at. Since TH posted a new corproate presentation we can be confident they were meeting with some investor(s) on Monday. Pre-market trading kicked in right after the news broke about the impending IV Push approval just after 7AM. I am not sure when the Zip Trader story got posted. 

Another possibility is Cantor being the buyer as they tried to build inventory of TH's stock to sell onto their clients following the conference this week.

jfm1330 wrote: I still have a hard time believing this guy and his falsehoods are the reason for the little run up. It is clear that he knows nothing about Thera and Trogarzo.


TH1902 wrote: Was curious so I found the video that referenced THTX, here it is, starts around 4:30 point, pitched as a trade on FDA response expected Oct. 3rd

https://www.youtube.com/watch?v=O6tkOY0GTVI

 

 




<< Previous
Bullboard Posts
Next >>